We also detected TET2 mutations in PTCL-NOS patients, but at a lower frequency than the other PTCL entities, which may due to the TFH-like subtype of PTCL-NOS. This evidence concerns the gene TET2 and mature T-cell and NK-cell non-Hodgkin lymphoma.